Aquestive Therapeutics Insider Trades

AQST

Track insider trading activity from Aquestive Therapeutics executives and directors. See which insiders are buying and selling AQST stock.

Trades Last 12 Months

All Insider Trades for Aquestive Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Barber Daniel President And CEO
Holding Value $2.9M 652,317 shares
Last Trade
Sep 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$121k 25,000 shares
$4.82
$4.44
Boyd Peter E. Chief People Officer
Holding Value $1.26M 284,024 shares
Last Trade
Sep 09, 2026 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$11.8k 2,293 shares
$5.15
$4.44
Korczynski Sherry Chief Commercial Officer
Holding Value $117k 26,250 shares
Last Trade
Sep 09, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$45.1k 8,750 shares
$5.15
$4.44
Jung Cassie Chief Operating Officer
Holding Value $918k 206,833 shares
Last Trade
Sep 03, 2026 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$24.5k 4,587 shares
$5.35
$4.44
Krop Julie Director
Holding Value $0 0 shares
Last Trade
Jun 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$126k 25,000 shares
$5.03
$4.44
Brown Gregory B Director
Holding Value $224k 50,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$4.44
Taglietti Marco Director
Holding Value $224k 50,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$4.44
Morris Timothy E Director
Holding Value $224k 50,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$4.44
Holding Value $224k 50,500 shares
Last Trade
Jun 10, 2026 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$4.44
Cochran John Director
Holding Value $224k 50,500 shares
Last Trade
Jun 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$201k 50,500 shares
$3.99
$4.44
Zalewski Thomas A. Chief Legal Officer
Holding Value $444k 100,000 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$724k 175,000 shares
$4.14
$4.44
Cioffi Melina Svp, Regulatory Affairs
Holding Value $1.21M 273,200 shares
Last Trade
May 15, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.95k 1,667 shares
$4.17
$4.44
Braender Lori J Corporate Secretary
Holding Value $1.03M 231,042 shares
Last Trade
May 07, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$574k 135,690 shares
$4.23
$4.44
Toth A Ernest Jr Chief Financial Officer
Holding Value $1.26M 283,460 shares
Last Trade
May 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$387k 92,652 shares
$4.18
$4.44
Greenhawt Matthew J. Chief Medical Officer
Holding Value $333k 75,000 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$536k 125,000 shares
$4.29
$4.44
Davis Matthew W. Chief Development Officer
Holding Value $444k 100,000 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$429k 100,000 shares
$4.29
$4.44
Kraus Carl N Chief Medical Officer
Holding Value $1.25M 282,475 shares
Last Trade
Oct 15, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$142k 20,272 shares
$7.00
$4.44
Morris Timothy E Director
Holding Value $186k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.44
Brown Gregory B Director
Holding Value $186k 42,000 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 42,000 shares
$3.41
$4.44
Wargacki Stephen Chief Science Officer
Holding Value $1.53M 343,552 shares
Last Trade
Mar 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11.6k 4,572 shares
$2.54
$4.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up